Veradigm Inc (PK:MDRX)

Business Focus: Medical Software & Technology Services

Mar 26, 2024 08:45 am ET

Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation

SAN DIEGO, March 26, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in Veradigm Inc., f.k.a. Allscripts Healthcare Solutions, Inc.

Feb 28, 2024 07:00 am ET

Veradigm Receives Expected Delisting Notice from Nasdaq

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, announced today that, as expected, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the common stock of the Company from Nasdaq (the “Decision”). The Deci

Feb 28, 2024 07:00 am ET

Veradigm to Participate in TD Cowen Annual Health Care Conference

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, today announced that Dr. Yin Ho, Veradigm interim Chief Executive Officer, and Lee Westerfield, interim Chief Financial Officer, will present at the TD Cowen Annual Health Care Conference on Monday, March 4, 2024, at 9:50 AM Eastern Time.

Feb 27, 2024 07:00 am ET

Veradigm Provides Update on its Financial Restatement Process

Veradigm Inc. (NASDAQ: MDRX) (the “Company”), a leading provider of healthcare data and technology products and solutions, announced today that the Company does not expect to have filed its Annual Report on Form 10-K for the year ended December 31, 2022, or its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023, June 30, 2023 and Septembe

Feb 27, 2024 07:00 am ET

Veradigm to Acquire ScienceIO

Veradigm Inc. (NASDAQ: MDRX) (the “Company”), a leading provider of healthcare data and technology products and solutions, today announced that it has signed a definitive agreement to acquire ScienceIO. The transaction has been unanimously approved by the Veradigm Board of Directors and is expected to close as promptly as practicable following the satisfaction of customary closing conditions.

Feb 22, 2024 08:01 am ET

Veradigm to Highlight New EHR-Integrated Care Gap Alert Solution at ViVE 2024 Conference

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that it will be highlighting the new

Feb 20, 2024 08:01 am ET

Veradigm Reveals New Insights on the Prevalence of Cardiovascular Conditions in the U.S.

Which region of the U.S. has the highest rates of hypertension, coronary artery disease and heart failure? The South, according to this analysis on cardiovascular disease (CVD) from Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions. Veradigm today released its inaugural

Feb 13, 2024 08:01 am ET

Veradigm and American College of Cardiology Launch Influenza Vaccination Education Initiative to Improve Cardiovascular Health

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANSFORM VAX, an American College of Cardiology (ACC)-sponsored initiative aimed at improving cardiovascular health through increased influenza vaccination education.

Feb 06, 2024 08:45 am ET

Lawsuit Notice: Investors who lost money with Veradigm Inc. (NASDAQ: MDRX) shares should contact the Shareholders Foundation

SAN DIEGO, Feb. 6, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in Veradigm Inc. (NASDAQ: MDRX) shares.

Jan 22, 2024 01:38 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Veradigm Inc.- MDRX

NEW YORK, Jan. 22, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Jan 22, 2024 12:49 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc.(MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

Levi & Korsinsky, LLP notifies investors in Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Veradigm investors who were adversely...

Jan 22, 2024 11:15 am ET

DEADLINE ALERT for MDRX, FSR, RBLX, and DG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....

Jan 22, 2024 07:00 am ET

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ: MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 21, 2024 08:24 pm ET

FINAL DEADLINE REMINDER FOR MDRX INVESTORS: Kessler Topaz Meltzer & Check, LLP Announces Final Lead Plaintiff Deadline in Securities Class Action Lawsuit Filed Against Veradigm Inc. (MDRX)

The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Veradigm Inc. (“Veradigm”)...

Jan 21, 2024 06:00 pm ET

MDRX DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important January 22 Deadline in Securitie

NEW YORK, Jan. 21, 2024 /PRNewswire/ --

Jan 21, 2024 11:12 am ET

MDRX DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important January 22 Deadline in Securitie

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) between February 26, 2021 and June 13, 2023, both dates inclusive (the “Class...

Jan 20, 2024 01:32 pm ET

MDRX 2-DAY DEADLINE ALERT: Veradigm (MDRX) Faces Class Action Lawsuit Alleging Accounting Fraud, Hagens Berman Encourages MDRX Investors with Substantial Losses to Contact Firm Before Jan. 22nd Deadli

Hagens Berman urges Veradigm Inc. (NASDAQ: MDRX) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 26, 2021 – June 13, 2023Lead Plaintiff Deadline: Jan. 22, 2024Visit: www.hbsslaw.com/investor-fraud/MDRX...

Jan 19, 2024 09:00 pm ET

VERADIGM DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) in the United States District Court...

Jan 19, 2024 03:33 pm ET

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Veradigm Inc. (MDRX)

The Law Offices of Frank R. Cruz reminds investors of the upcoming January 22, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ:

Jan 19, 2024 09:15 am ET

Deadline in 3 Days for Veradigm Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Veradigm Inc. (MDRX) Investors of Filing Deadline in Class Action Lawsuit

RADNOR, Pa., Jan. 19, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Veradigm Inc. ("Veradigm") (NASDAQ: MDRX). The action charges Veradigm with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Veradigm's materially misleading statements and omissions to the public, Veradi

Jan 19, 2024 05:00 am ET

FINAL DEADLINE MONDAY: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 19, 2024 04:45 am ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Veradigm Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2024 - (NASDAQ: MDRX)

NEW YORK, Jan. 19, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Veradigm Inc..

Jan 18, 2024 03:45 pm ET

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 18, 2024 01:02 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc. (MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

Jan 18, 2024 12:40 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Veradigm Inc. - MDRX

Pomerantz LLP announces that a class action lawsuit has been filed against Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW),...

Jan 18, 2024 10:00 am ET

VERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss The

If you suffered losses exceeding $100,000 investing in Veradigm securities between February 26, 2021 and December 7, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/MDRX.

Jan 18, 2024 04:45 am ET

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Veradigm Investors of a Lead Plaintiff Deadline of January 22, 2024

NEW YORK, Jan. 18, 2024 /PRNewswire/ -- Attention Veradigm Inc. ("Veradigm") (NASDAQ: MDRX) shareholders:

Jan 17, 2024 06:26 pm ET

MDRX DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors with Losses to Secure Counsel Before Important January 22 Deadline in

Jan 17, 2024 12:07 pm ET

DEADLINE ALERT for MDRX, FSR, RBLX, and DG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Jan 17, 2024 11:44 am ET

MDRX 5-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Veradigm (MDRX) Investors with Substantial Losses to Contact Firm Before Jan. 22nd Deadline in Class Action Lawsuit Alleg

Jan 17, 2024 11:00 am ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Veradigm Inc. (MDRX)

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 22, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Veradigm Inc. (“Veradigm” or the...

Jan 17, 2024 10:15 am ET

VERADIGM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discus

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) and reminds investors of the January 22, 2024 deadline to seek the role of lead...

Jan 17, 2024 09:31 am ET

Veradigm Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information

A class action lawsuit has been filed against Veradigm, Inc. (NASDAQ: MDRX) for securities law violations. Investors who purchased shares and have lost money are encouraged to contact the firm to learn more about how they might recover those...

Jan 17, 2024 07:00 am ET

6-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of 20(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 16, 2024 07:25 pm ET

MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Veradigm, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MDRX

Robbins Geller Rudman & Dowd LLP announces that purchasers of Veradigm Inc. (NASDAQ: MDRX) common stock between February 26, 2021 and December 7, 2023, all dates inclusive (the “Class Period”), have until Monday, January 22, 2024 to seek...

Jan 16, 2024 02:55 pm ET

MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit

LOS ANGELES, Jan. 16, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX).

Jan 16, 2024 05:00 am ET

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 16, 2024 04:45 am ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc.(MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Jan. 16, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX) of a class action securities lawsuit.

Jan 15, 2024 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, Microvast, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Veradigm Inc. (NASDAQ: MDRX), Fisker Inc. (NYSE: FSR), Microvast Holdings, Inc....

Jan 15, 2024 12:32 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc. (MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

Jan 15, 2024 05:00 am ET

JANUARY 22 DEADLINE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 14, 2024 05:30 pm ET

ROSEN, A TOP RANKED LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors with to Secure Counsel Before Important January 22 Deadline in Securities Class Action - MD

NEW YORK, Jan. 14, 2024 /PRNewswire/ --

Jan 14, 2024 03:58 pm ET

Veradigm’s (MDRX) New Management Team Reduces Guidance Amid Class Action Lawsuit Alleging Accounting Fraud - Hagens Berman

Jan 14, 2024 10:10 am ET

Final Deadline Approaching for MDRX Investors: Kessler Topaz Meltzer & Check, LLP Reminds Veradigm Inc. (MDRX) Investors of Class Action Lawsuit Deadline on January 22, 2024

Jan 14, 2024 09:45 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Veradigm Inc. - MDRX

NEW YORK, Jan. 14, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Jan 12, 2024 06:59 pm ET

ROSEN, LEADING INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors with to Secure Counsel Before Important January 22 Deadline in Securities Class Action –

Jan 12, 2024 04:45 am ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Veradigm Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2024 - (NASDAQ: MDRX)

NEW YORK, Jan. 12, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Veradigm Inc..

Jan 11, 2024 11:50 pm ET

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 11, 2024 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm

Jan 11, 2024 12:56 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc. (MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

Jan 11, 2024 12:27 pm ET

Veradigm (MDRX) Faces Securities Fraud Lawsuit Alleging Accounting Fraud, New Management Team Reduces Guidance- Hagens Berman

Jan 11, 2024 11:45 am ET

VERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss The

Jan 11, 2024 10:00 am ET

MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit

LOS ANGELES, Jan. 11, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX).

Jan 11, 2024 04:45 am ET

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Veradigm Investors of a Lead Plaintiff Deadline of January 22, 2024

NEW YORK, Jan. 11, 2024 /PRNewswire/ -- Attention Veradigm Inc. ("Veradigm") (NASDAQ: MDRX) shareholders:

Jan 10, 2024 11:50 pm ET

IMPORTANT JANUARY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 10, 2024 07:16 pm ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Veradigm Inc. (MDRX)

Jan 10, 2024 01:49 pm ET

Robbins LLP Reminds Veradigm Inc. Investors of Pending Lead Plaintiff Deadline in MRDX Class Action

Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Veradigm Inc. (NASDAQ: MDRX) securities between February 26, 2021 and June 13, 2023. Veradigm...

Jan 10, 2024 11:29 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Veradigm Inc. - MDRX

Pomerantz LLP is investigating claims on behalf of investors of Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The...

Jan 10, 2024 10:45 am ET

VERADIGM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discus

Jan 10, 2024 10:30 am ET

MDRX Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed against Veradigm Inc. (MDRX)

RADNOR, Pa., Jan. 10, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Veradigm Inc. ("Veradigm") (NASDAQ: MDRX). The action charges Veradigm with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Veradigm's materially misleading statements and omissions to the public, Veradig

Jan 10, 2024 08:01 am ET

New Veradigm Leadership Provides Outlook on Business and Strategy, and Refreshed Financial Estimates for Fiscal 2023

The new leadership team at Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, has provided refreshed estimated, unaudited ranges of financial information for fiscal 2023. Dr. Shih-Yin Ho, Interim CEO, and Lee Westerfield, Interim CFO, will discuss Veradigm’s mission, business and operations, and innovation

Jan 09, 2024 10:45 pm ET

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 09, 2024 03:39 pm ET

MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit

BENSALEM, Pa., Jan. 9, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX).

Jan 09, 2024 08:04 am ET

Veradigm Selects MedAllies as its Qualified Health Information Network™ (QHIN™ ) Partner

Providers using Veradigm EHRs to gain access to longitudinal patient records, improving interoperability and driving better treatment decisions

Jan 09, 2024 07:00 am ET

FINAL DEADLINE THIS MONTH: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

Jan 09, 2024 04:45 am ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc.(MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Jan. 9, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX) of a class action securities lawsuit.

Jan 08, 2024 08:01 pm ET

Kessler Topaz Meltzer & Check, LLP Reminds Veradigm Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the Firm

The law firm of Kessler Topaz Meltzer & Check, LLP (

Jan 08, 2024 05:38 pm ET

MDRX 2-WEEK DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Veradigm (MDRX) Investors with Substantial Losses to Contact Firm’s Attorneys Before Jan. 22nd Deadline in Securities Fr

Jan 08, 2024 03:05 pm ET

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important January 22 Deadline in Securities Class Action – M

Jan 08, 2024 02:35 pm ET

DEADLINE ALERT for SKIN, SMR, SLRN, MDRX: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....

Jan 08, 2024 12:53 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc. (MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

Jan 08, 2024 12:07 pm ET

DEADLINE ALERT for SLRN, SKIN, SMR, and MDRX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Jan 08, 2024 04:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 07, 2024 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm

Jan 07, 2024 02:30 pm ET

ROSEN, A LONGSTANDING LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - MDRX

NEW YORK, Jan. 7, 2024 /PRNewswire/ --

Jan 06, 2024 07:41 pm ET

Important January 22, 2024 MDRX Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Veradigm Inc. (MDRX) Investors of Securities Fraud Class Action Lawsuit

Jan 06, 2024 09:30 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Veradigm Inc. - MDRX

NEW YORK, Jan. 6, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Jan 05, 2024 07:49 pm ET

EXPANDED CLASS PERIOD NOTICE: Robbins Geller Rudman & Dowd LLP Files Amended Class Action Lawsuit Against Veradigm Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Veradigm Inc. (NASDAQ: MDRX) common stock between February 26, 2021 and December 7, 2023, inclusive (the “Class Period”) have until January 22, 2024 to seek appointment as lead plaintiff of the

Jan 05, 2024 02:49 pm ET

Berman Tabacco Announces Investigation of Veradigm Inc. (MDRX) for Potential Securities Law Violations

Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX). About the Investigation A securities class action has been filed in...

Jan 05, 2024 01:58 pm ET

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Veradigm (MDRX) Investors with Substantial Losses to Contact Firm, Securities Fraud Lawsuit Filed

Jan 05, 2024 01:09 pm ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Veradigm Inc. (MDRX)

Jan 05, 2024 10:30 am ET

VERADIGM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly

Jan 05, 2024 06:00 am ET

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 05, 2024 04:45 am ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Veradigm Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2024 - (NASDAQ: MDRX)

NEW YORK, Jan. 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Veradigm Inc..

Jan 04, 2024 09:15 pm ET

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – MDRX

Jan 04, 2024 04:01 pm ET

Veradigm Leadership Team to Present at J.P. Morgan Healthcare Conference

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that Dr. Shih-Yin Ho, Veradigm interim Chief Executive Officer and board member, and Lee Westerfield, interim Chief Financial Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 11:15 AM PST.

Jan 04, 2024 01:08 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc. (MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

Jan 04, 2024 12:06 pm ET

DEADLINE ALERT for SLRN, SKIN, SMR, and MDRX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Jan 04, 2024 09:15 am ET

VERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss The

If you suffered losses exceeding $100,000 investing in Veradigm securities between February 26, 2021 and June 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/MDRX.

Jan 04, 2024 07:00 am ET

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 03, 2024 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Holley, Veradigm, and Fisker and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Holley Inc. (NYSE: HLLY), Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ:...

Jan 03, 2024 01:48 pm ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Veradigm Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2024 – (NASDAQ: MDRX)

The Gross Law Firm issues the following notice to shareholders of Veradigm Inc.. Shareholders who purchased shares of MDRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment...

Jan 03, 2024 01:00 pm ET

DEADLINE ALERT for SKIN, SMR, SLRN, MDRX: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Jan 03, 2024 09:34 am ET

INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Veradigm Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit - MDRX

Robbins Geller Rudman & Dowd LLP announces that purchasers of Veradigm Inc. (NASDAQ: MDRX) common stock between February 26, 2021 and June 13, 2023, inclusive (the “Class Period”), have until January 22, 2024 to seek appointment as lead plaintiff...

Jan 03, 2024 06:30 am ET

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 02, 2024 04:01 pm ET

Veradigm Strengthens Award-Winning Revenue Cycle Services Portfolio with Acquisition of Full-Service RCM Company

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the acquisition of Koha Health, a full-service revenue cycle management (RCM) company. With this acquisition, Veradigm further adds to its depth of offerings and expertise as a leading provider of revenue cycle services in the ambulatory healthcare

Jan 02, 2024 01:07 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Veradigm Inc. - MDRX

Jan 02, 2024 11:00 am ET

MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit

LOS ANGELES, Jan. 2, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX).

Jan 02, 2024 10:45 am ET

Kessler Topaz Meltzer & Check, LLP Notifies Veradigm Inc. Investors of Securities Fraud Class Action Lawsuit Filed on Their Behalf

RADNOR, Pa., Jan. 2, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Veradigm Inc. ("Veradigm") (NASDAQ: MDRX). The action charges Veradigm with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Veradigm's materially misleading statements and omissions to the public, Veradi

Jan 02, 2024 04:45 am ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc.(MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Jan. 2, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX) of a class action securities lawsuit.

Jan 01, 2024 09:45 pm ET

INVESTOR ACTION DEADLINE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jan 01, 2024 09:39 am ET

Investors Sue Veradigm (MDRX) For Allegedly Inflating Revenues- Hagens Berman

Dec 31, 2023 02:30 pm ET

ROSEN, A LONGSTANDING LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDRX

Dec 30, 2023 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Holley, Veradigm, and Fisker and Encourages Investors to Contact the Firm

Dec 29, 2023 02:26 pm ET

ROSEN, A LEADING LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MDRX

NEW YORK, Dec. 29, 2023 /PRNewswire/ --

Dec 29, 2023 01:56 pm ET

Veradigm (MDRX) CEO and CFO Ousted Amid Class Action Lawsuit Alleging Accounting Fraud- Hagens Berman

Dec 29, 2023 03:15 am ET

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 29, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 28, 2023 07:05 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Veradigm Inc. - MDRX

NEW YORK, Dec. 28, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Dec 28, 2023 05:46 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Veradigm Inc. - MDRX

Dec 28, 2023 05:10 pm ET

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – M

Dec 28, 2023 01:04 pm ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Veradigm Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2024 – (NASDAQ: MDRX)

Dec 28, 2023 12:07 pm ET

DEADLINE ALERT for SLRN, SKIN, SMR, and MDRX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Dec 28, 2023 10:00 am ET

MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit

LOS ANGELES, Dec. 28, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX).

Dec 28, 2023 08:15 am ET

VERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss The

Dec 28, 2023 03:00 am ET

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 28, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 27, 2023 12:52 pm ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Veradigm Inc. (MDRX)

Dec 27, 2023 09:45 am ET

VERADIGM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discus

Dec 27, 2023 04:45 am ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc.(MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Dec. 27, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX) of a class action securities lawsuit.

Dec 26, 2023 10:45 pm ET

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 26, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 26, 2023 09:00 pm ET

VERADIGM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm

Dec 26, 2023 02:34 pm ET

MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit

BENSALEM, Pa., Dec. 26, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX).

Dec 26, 2023 04:45 am ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc.(MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Dec. 26, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX) of a class action securities lawsuit.

Dec 25, 2023 11:11 am ET

Veradigm (MDRX) CEO and CFO Ousted Amid Class Action Lawsuit Alleging Accounting Fraud- Hagens Berman

Dec 24, 2023 10:50 pm ET

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 24, 2023 07:45 pm ET

Kessler Topaz Meltzer & Check, LLP Reminds Veradigm Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm

RADNOR, Pa., Dec. 24, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Veradigm Inc. ("Veradigm") (NASDAQ: MDRX). The action charges Veradigm with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Veradigm's materially misleading statements and omissions to the public, Verad

Dec 24, 2023 02:47 pm ET

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDRX

Dec 22, 2023 09:00 pm ET

VERADIGM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm

Dec 22, 2023 08:42 pm ET

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MDRX

NEW YORK, Dec. 22, 2023 /PRNewswire/ --

Dec 22, 2023 01:01 pm ET

Veradigm Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information

Dec 22, 2023 11:55 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Veradigm Inc. - MDRX

Dec 22, 2023 11:37 am ET

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Veradigm Inc. (MDRX) Investors and Encourages Investors to Contact the Firm Before January 22, 2024

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on behalf of those who acquired Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX)...

Dec 22, 2023 11:23 am ET

Veradigm (MDRX) CEO and CFO Ousted Amid Class Action Lawsuit Alleging Accounting Fraud- Hagens Berman

Dec 22, 2023 07:00 am ET

FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 22, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 21, 2023 01:13 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc. (MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

Dec 21, 2023 08:15 am ET

VERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss The

Dec 21, 2023 07:00 am ET

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 21, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 20, 2023 01:11 pm ET

DEADLINE ALERT for SKIN, SMR, SLRN, MDRX: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Dec 20, 2023 12:18 pm ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Veradigm Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2024 – (NASDAQ: MDRX)

The Gross Law Firm issues the following notice to shareholders of Veradigm Inc. Shareholders who purchased shares of MDRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment...

Dec 20, 2023 12:07 pm ET

DEADLINE ALERT for SLRN, SKIN, SMR, and MDRX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Dec 20, 2023 12:04 pm ET

MDRX Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Veradigm Inc. (MDRX) Investors of Securities Fraud Class Action Lawsuit

Dec 20, 2023 12:05 am ET

INVESTOR ACTION DEADLINE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 20, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 19, 2023 11:00 am ET

MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit

LOS ANGELES, Dec. 19, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX).

Dec 19, 2023 09:45 am ET

VERADIGM ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Di

Dec 19, 2023 05:45 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 19, 2023 04:45 am ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc.(MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Dec. 19, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX) of a class action securities lawsuit.

Dec 18, 2023 04:03 pm ET

MDRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Veradigm Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Veradigm Inc. (NASDAQ: MDRX) common stock between February 26, 2021 and June 13, 2023, inclusive (the “Class Period”), have until January 22, 2024 to seek appointment as...

Dec 18, 2023 03:48 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Veradigm Inc. - MDRX

NEW YORK, Dec. 18, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Dec 18, 2023 03:37 pm ET

Veradigm (MDRX) Faces Lawsuit for Inflating Revenues- Hagens Berman

Dec 18, 2023 11:00 am ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Veradigm Inc. (MDRX)

Dec 18, 2023 06:59 am ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc.(MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

Dec 18, 2023 04:45 am ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Veradigm Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2024 - (NASDAQ: MDRX)

NEW YORK, Dec. 18, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Veradigm Inc.

Dec 18, 2023 01:20 am ET

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 18, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 17, 2023 09:00 pm ET

VERADIGM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm

Dec 17, 2023 04:26 pm ET

Lowey Dannenberg Notifies Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact

Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) for violations of the federal...

Dec 17, 2023 02:04 pm ET

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDRX

Dec 15, 2023 08:45 pm ET

ROSEN, A LEADING NATIONAL FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MDRX

NEW YORK, Dec. 15, 2023 /PRNewswire/ --

Dec 15, 2023 05:10 pm ET

Veradigm (MDRX) Receives Nasdaq Notice Over Delayed Financial Filings in Wake of Investor Class Action- Hagens Berman

Dec 15, 2023 03:10 pm ET

MDRX ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit against Veradigm Inc. (MDRX)

RADNOR, Pa., Dec. 15, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Veradigm Inc. ("Veradigm") (NASDAQ: MDRX). The action charges Veradigm with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Veradigm's materially misleading statements and omissions to the public, Veradig

Dec 15, 2023 09:45 am ET

VERADIGM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly

Dec 14, 2023 03:30 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Veradigm Inc. - MDRX

Dec 14, 2023 01:10 pm ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Veradigm Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2024 – (NASDAQ: MDRX)

Dec 14, 2023 11:00 am ET

DEADLINE ALERT for SKIN, SMR, SLRN, MDRX: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Dec 13, 2023 11:55 pm ET

IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 13, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 13, 2023 04:13 pm ET

MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit

LOS ANGELES, Dec. 13, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX).

Dec 13, 2023 04:05 pm ET

Veradigm Inc. Announces that Nasdaq Hearings Panel has Granted its Continued Listing, Pending Return to Compliance with Nasdaq Filing Requirements

Veradigm Inc. (NASDAQ: MDRX (the “Company”)) announced today that it received a decision from the Nasdaq Hearings Panel (the “Panel”) granting its request for continued listing on the Nasdaq Capital Market, subject to the Company demonstrating compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rules”) on or before February 27, 2024, and certain other conditions, including the achievement of various interim milestones (the “Panel Decision”).

Dec 13, 2023 12:33 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc.(MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

Dec 13, 2023 12:07 pm ET

DEADLINE ALERT for SLRN, SKIN, SMR, and MDRX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Dec 13, 2023 09:30 am ET

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Veradigm Inc. (MDRX) Investors and Encourages Investors to Contact the Firm Before January 22, 2024

Dec 13, 2023 07:00 am ET

FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

Dec 13, 2023 12:48 am ET

MDRX STOCK NEWS: Veradigm Inc. Investors Should Contact Robbins LLP About the Securities Fraud Class Action

Dec 12, 2023 09:24 pm ET

Veradigm Inc. investors: Please contact the Portnoy Law Firm to recover your losses; January 22, 2024 deadline

The Portnoy Law Firm advises Veradigm Inc. (NASDAQ: MDRX) investors that a lawsuit was filed on behalf of investors that purchased Veradigm securities between February 26, 2021 and June 13, 2023, inclusive (the “Class Period”). Investors are...

Dec 12, 2023 09:00 pm ET

VERADIGM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm

Dec 12, 2023 02:55 pm ET

ROSEN, A LEADING LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – MDRX

Dec 12, 2023 01:00 pm ET

Lowey Dannenberg Notifies Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact

Dec 12, 2023 09:07 am ET

MDRX ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Veradigm Inc.

The law firm of Kessler Topaz Meltzer & Check, LLP (

Dec 12, 2023 07:15 am ET

Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of I

Upcoming Lead Plaintiff Deadline is January 22, 2024

Dec 12, 2023 07:00 am ET

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 12, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 12, 2023 04:45 am ET

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc.(MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Dec. 12, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX) of a class action securities lawsuit.

Dec 11, 2023 06:19 pm ET

Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Veradigm Inc.

Dec 11, 2023 02:05 pm ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Veradigm Inc. (MDRX)

Dec 11, 2023 12:59 pm ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Veradigm Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2024 – (NASDAQ: MDRX)

Dec 11, 2023 12:29 pm ET

Veradigm (MDRX) Receives Nasdaq Notice Over Delayed Financial Filings in Wake of Investor Class Action- Hagens Berman

Dec 11, 2023 08:01 am ET

Veradigm to Enhance Independent Practice Financial Management with AI for Practice Fusion Billing Services

Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that it will now offer a conversational artificial intelligence (AI) agent for Practice Fusion Billing Services, a Veradigm Network solution. Created to quickly answer questions in a conversational format designed to meet client needs, this enha

Dec 11, 2023 06:00 am ET

IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 11, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 10, 2023 08:00 am ET

VERADIGM ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Opti

Dec 09, 2023 08:02 am ET

MDRX INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Reminds Veradigm Investors of a Class Action Lawsuit and Upcoming Deadline

Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of the common stock of Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX), a healthcare technology company, between February 26, 2021 and...

Dec 08, 2023 07:00 pm ET

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDRX

Dec 08, 2023 04:51 pm ET

Veradigm Inc. investors: Please contact the Portnoy Law Firm to recover your losses; January 22, 2024 deadline

Dec 08, 2023 02:45 pm ET

MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit

BENSALEM, Pa., Dec. 8, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX).

Dec 08, 2023 02:20 pm ET

VERADIGM SHAREHOLDER UPDATE: Kaplan Fox & Kilsheimer LLP Reminds Veradigm Investors of Upcoming Deadline

Kaplan Fox & Kilsheimer LLP reminds shareholders that a complaint has been filed on behalf of purchasers of the common stock of Veradigm Inc (“Veradigm” or the “Company”) (NASDAQ: MDRX), a healthcare technology company, between February 26, 2021...

Dec 08, 2023 08:45 am ET

Veradigm Inc. Announces Leadership Transition

Veradigm Inc. (Nasdaq: MDRX) announced today that the Company’s Board of Directors appointed current Chairman, Greg Garrison, as Executive Chairman, and current director, Dr. Shih-Yin (“Yin”) Ho, as interim Chief Executive Officer. In addition, Lee Westerfield, who brings more than 25 years of experience as a senior financial executive, most recently serving as Chief Financial Officer at Clearsense, will be serving as Interim Chief Financial Officer. Chief Executive Officer Richard J. Poulton has resigned at the request of the Board from his role as CEO and has stepped down from the Board. Als

Dec 07, 2023 11:55 pm ET

IMPORTANT DEADLINE ALERT: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 7, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 07, 2023 09:00 pm ET

VERADIGM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm

Dec 07, 2023 05:39 pm ET

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Veradigm Inc. (MDRX) Investors and Encourages Investors to Contact the Firm Before January 22, 2024

Dec 07, 2023 05:05 pm ET

Veradigm Inc. (MDRX) Investors with Large Losses Should Contact Robbins LLP for Information About Their Rights and Remedies

Dec 07, 2023 03:50 pm ET

Veradigm (MDRX) Receives Nasdaq Notice Over Delayed Financial Filings in Wake of Investor Class Action- Hagens Berman

Dec 07, 2023 02:45 pm ET

ROSEN, A RANKED AND LEADING FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MDRX

NEW YORK, Dec. 7, 2023 /PRNewswire/ --

Dec 07, 2023 12:06 pm ET

DEADLINE ALERT for SLRN, SKIN, SMR, and MDRX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Dec 07, 2023 05:30 am ET

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 7, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "the Company") (NASDAQ:MDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dec 06, 2023 12:03 pm ET

You are here

Veradigm Inc (PK:MDRX)

Business Focus: Medical Software & Technology Services